Kyverna Therapeutics, Inc. KYTX Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Kyverna Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s return on assets?
- Kyverna Therapeutics, Inc. (KYTX) reported return on assets of -60.4% in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s return on assets changed year-over-year?
- Kyverna Therapeutics, Inc.'s return on assets decreased by 35.2% year-over-year, from -44.7% to -60.4%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.